A Study to Evaluate the Effect of Coadministration of a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of BMS-986205 in Healthy Subjects
Latest Information Update: 24 Sep 2019
At a glance
- Drugs Linrodostat (Primary) ; Omeprazole
- Indications Bladder cancer; Cancer; Head and neck cancer; Liver cancer; Malignant melanoma; Solid tumours
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
Most Recent Events
- 25 Jul 2019 Status changed from active, no longer recruiting to completed.
- 21 Jun 2019 Status changed from not yet recruiting to active, no longer recruiting.
- 07 May 2019 New trial record